{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:29:01Z","timestamp":1791296941193,"version":"4.1.0"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,4,29]],"date-time":"2012-04-29T00:00:00Z","timestamp":1335657600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s11910-012-0269-4","type":"journal-article","created":{"date-parts":[[2012,4,27]],"date-time":"2012-04-27T23:44:57Z","timestamp":1335570297000},"page":"294-301","source":"Crossref","is-referenced-by-count":51,"title":["Molecular Therapies for Tuberous Sclerosis and Neurofibromatosis"],"prefix":"10.1007","volume":"12","author":[{"given":"David Neal","family":"Franz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian D.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,4,29]]},"reference":[{"issue":"2","key":"269_CR1","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1056\/NEJMra052603","volume":"354","author":"CH Pui","year":"2006","unstructured":"Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med. 2006;354(2):166\u201378.","journal-title":"N Engl J Med"},{"issue":"12","key":"269_CR2","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1038\/sj.leu.2401939","volume":"14","author":"PS Gaynon","year":"2000","unstructured":"Gaynon PS, Trigg ME, Heerema NA, Sensel MG, Sather HN, Hammond GD, et al. Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983\u20131995. Leukemia. 2000;14(12):2223\u201333.","journal-title":"Leukemia"},{"key":"269_CR3","first-page":"865","volume":"11","author":"C Rechnitzer","year":"2011","unstructured":"Rechnitzer C. Increased survival of children with solid tumours: how did we get there and how to keep the success going? Canc Imag. 2011;11:865\u20139.","journal-title":"Canc Imag"},{"key":"269_CR4","unstructured":"Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, et al. SEER Cancer Statistics Review, 1975\u20132008. National Cancer Institute, Bethesda, MD; 2010."},{"key":"269_CR5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1600-065X.2000.imr017511.x","volume":"175","author":"A Stoddart","year":"2000","unstructured":"Stoddart A, Fleming HE, Paige CJ. The role of the preBCR, the interleukin-7 receptor, and homotypic interactions during B-cell development. Immunol Rev. 2000;175:47\u201358.","journal-title":"Immunol Rev"},{"issue":"24","key":"269_CR6","doi-asserted-by":"crossref","first-page":"8573","DOI":"10.1073\/pnas.0503224102","volume":"102","author":"CM Johannessen","year":"2005","unstructured":"Johannessen CM, Reczek EE, James MF, Brems H, Legius E, Cichowski K. The NF1 tumor suppressor critically regulates TSC2 and mTOR. Proc Natl Acad Sci U S A. 2005;102(24):8573\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"269_CR7","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1158\/0008-5472.CAN-04-4058","volume":"65","author":"B Dasgupta","year":"2005","unstructured":"Dasgupta B, Yi Y, Chen DY, Weber JD, Gutmann DH. Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1-associated human and mouse brain tumors. Cancer Res. 2005;65(7):2755\u201360.","journal-title":"Cancer Res"},{"issue":"4","key":"269_CR8","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1001\/archderm.143.4.504","volume":"143","author":"B Perry","year":"2007","unstructured":"Perry B, Banyard J, McLaughlin ER, Watnick R, Sohn A, Brindley DN, et al. AKT1 overexpression in endothelial cells leads to the development of cutaneous vascular malformations in vivo. Arch Dermatol. 2007;143(4):504\u20136.","journal-title":"Arch Dermatol"},{"issue":"7","key":"269_CR9","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrc839","volume":"2","author":"I Vivanco","year":"2002","unstructured":"Vivanco I, Sawyers CL. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer. 2002;2(7):489\u2013501.","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"269_CR10","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1158\/0008-5472.CAN-08-4884","volume":"69","author":"F Chiarini","year":"2009","unstructured":"Chiarini F, Fala F, Tazzari PL, Ricci F, Astolfi A, Pession A, et al. Dual inhibition of class IA phosphatidylinositol 3-kinase and mammalian target of rapamycin as a new therapeutic option for T-cell acute lymphoblastic leukemia. Cancer Res. 2009;69(8):3520\u20138.","journal-title":"Cancer Res"},{"key":"269_CR11","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/978-3-642-18930-2_20","volume":"279","author":"PJ Houghton","year":"2004","unstructured":"Houghton PJ, Huang S. mTOR as a target for cancer therapy. Curr Top Microbiol Immunol. 2004;279:339\u201359.","journal-title":"Curr Top Microbiol Immunol"},{"issue":"5","key":"269_CR12","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nrc1362","volume":"4","author":"MA Bjornsti","year":"2004","unstructured":"Bjornsti MA, Houghton PJ. The TOR pathway: a target for cancer therapy. Nat Rev Cancer. 2004;4(5):335\u201348.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"269_CR13","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.devcel.2007.03.020","volume":"12","author":"PT Bhaskar","year":"2007","unstructured":"Bhaskar PT, Hay N. The two TORCs and Akt. Developmental Cell. 2007;12(4):487\u2013502.","journal-title":"Developmental Cell"},{"issue":"5712","key":"269_CR14","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.1106148","volume":"307","author":"DD Sarbassov","year":"2005","unstructured":"Sarbassov DD, Guertin DA, Ali SM, Sabatini DM. Phosphorylation and regulation of Akt\/PKB by the rictor-mTOR complex. Science. 2005;307(5712):1098\u2013101.","journal-title":"Science"},{"issue":"6","key":"269_CR15","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1634\/theoncologist.5-6-477","volume":"5","author":"BR Korf","year":"2000","unstructured":"Korf BR. Malignancy in neurofibromatosis type 1. Oncologist. 2000;5(6):477\u201385.","journal-title":"Oncologist"},{"issue":"6","key":"269_CR16","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/1098-1004(200006)15:6<541::AID-HUMU6>3.0.CO;2-N","volume":"15","author":"LM Messiaen","year":"2000","unstructured":"Messiaen LM, Callens T, Mortier G, Beysen D, Vandenbroucke I, Van RN, et al. Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects. Hum Mutat. 2000;15(6):541\u201355.","journal-title":"Hum Mutat"},{"key":"269_CR17","unstructured":"US Department of Health and Human Services, National Institutes of Health. Neurofibromatosis. NIH Consens Statement Online 1987 Jul 13\u201315;6(12):1\u201319."},{"issue":"1","key":"269_CR18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/(SICI)1096-8628(19990326)89:1<31::AID-AJMG7>3.0.CO;2-W","volume":"89","author":"BR Korf","year":"1999","unstructured":"Korf BR. Plexiform neurofibromas. Am J Med Genet. 1999;89(1):31\u20137.","journal-title":"Am J Med Genet"},{"key":"269_CR19","doi-asserted-by":"crossref","first-page":"8422","DOI":"10.1200\/JCO.2005.01.4886","volume":"23","author":"M Carli","year":"2005","unstructured":"Carli M, Ferrari A, Mattke A, et al. Pediatric malignant peripheral nerve sheath tumor: The Italian and German soft tissue sarcoma cooperative group. J Clin Oncol. 2005;23:8422\u201330.","journal-title":"J Clin Oncol"},{"key":"269_CR20","first-page":"311","volume":"39","author":"DG Evans","year":"2002","unstructured":"Evans DG, Baser ME, McGaughran J, Sharif S, Howard E, Moran A. Malignant peripheral nerve sheath tumours in neurofibromatosis. J Mol Genet. 2002;39:311\u20134.","journal-title":"J Mol Genet"},{"issue":"5","key":"269_CR21","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0022-3476(97)70092-1","volume":"131","author":"MN Needle","year":"1997","unstructured":"Needle MN, Cnaan A, Dattilo J, Chatten J, Phillips PC, Shochat S, et al. Prognostic signs in the surgical management of plexiform neurofibroma: the Children's Hospital of Philadelphia experience, 1974\u20131994. J Pediatr. 1997;131(5):678\u201382.","journal-title":"J Pediatr"},{"issue":"Pt 6","key":"269_CR22","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1093\/brain\/111.6.1355","volume":"111","author":"SM Huson","year":"1988","unstructured":"Huson SM, Harper PS, Compston DA. Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales. Brain. 1988;111(Pt 6):1355\u201381.","journal-title":"Brain"},{"key":"269_CR23","volume-title":"Neurofibromitosis: phenotype, natural history and pathogenesis","author":"VM Ricardi","year":"1986","unstructured":"Ricardi VM, Eichner JE. Neurofibromitosis: phenotype, natural history and pathogenesis. Baltimore: Johns Hopkins University Press; 1986."},{"issue":"5","key":"269_CR24","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1086\/320121","volume":"68","author":"SA Rasmussen","year":"2001","unstructured":"Rasmussen SA, Yang Q, Friedman JM. Mortality in neurofibromatosis 1: an analysis using U.S. death certificates. Am J Hum Genet. 2001;68(5):1110\u20138.","journal-title":"Am J Hum Genet"},{"key":"269_CR25","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.compmedimag.2004.03.002","volume":"28","author":"J Solomon","year":"2004","unstructured":"Solomon J, Warren K, Dombi E, et al. Automated detection and volume measurement of plexiform neurofibromas in neurofibromatosis 1 using magnetic resonance imaging. Comput Med Imag Graph. 2004;28:257\u201365.","journal-title":"Comput Med Imag Graph"},{"issue":"1","key":"269_CR26","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1212\/01.WNL.0000042321.94839.78","volume":"60","author":"A Gupta","year":"2003","unstructured":"Gupta A, Cohen BH, Ruggieri P, Packer RJ, Phillips PC. Phase I study of thalidomide for the treatment of plexiform neurofibroma in neurofibromatosis 1. Neurology. 2003;60(1):130\u20132.","journal-title":"Neurology"},{"issue":"3","key":"269_CR27","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1200\/JCO.2005.03.8638","volume":"24","author":"BC Widemann","year":"2006","unstructured":"Widemann BC, Salzer WL, Arceci RJ, Blaney SM, Fox E, End D, et al. Phase I trial and pharmacokinetic study of the farnesyltransferase inhibitor tipifarnib in children with refractory solid tumors or neurofibromatosis type I and plexiform neurofibromas. J Clin Oncol. 2006;24(3):507\u201316.","journal-title":"J Clin Oncol"},{"issue":"5","key":"269_CR28","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.pediatrneurol.2007.01.009","volume":"36","author":"D Babovic-Vuksanovic","year":"2007","unstructured":"Babovic-Vuksanovic D, Widemann BC, Dombi E, Gillespie A, Wolters PL, Toledo-Tamula MA, et al. Phase I trial of pirfenidone in children with neurofibromatosis 1 and plexiform neurofibromas. Pediatr Neurol. 2007;36(5):293\u2013300.","journal-title":"Pediatr Neurol"},{"issue":"13","key":"269_CR29","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMra055323","volume":"355","author":"PB Crino","year":"2006","unstructured":"Crino PB, Nathanson KL, Henske EP. The tuberous sclerosis complex. N Engl J Med. 2006;355(13):1345\u201356.","journal-title":"N Engl J Med"},{"issue":"9639","key":"269_CR30","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(08)61279-9","volume":"372","author":"P Curatolo","year":"2008","unstructured":"Curatolo P, Bombardieri R, Jozwiak S. Tuberous sclerosis. Lancet. 2008;372(9639):657\u201368.","journal-title":"Lancet"},{"issue":"5","key":"269_CR31","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1055\/s-0030-1269906","volume":"41","author":"DN Franz","year":"2010","unstructured":"Franz DN, Bissler JJ, McCormack FX. Tuberous sclerosis complex: neurological, renal and pulmonary manifestations. Neuropediatrics. 2010;41(5):199\u2013208.","journal-title":"Neuropediatrics"},{"issue":"9","key":"269_CR32","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1007\/s00247-008-0832-y","volume":"38","author":"HJ Baskin Jr","year":"2008","unstructured":"Baskin Jr HJ. The pathogenesis and imaging of the tuberous sclerosis complex. Pediatr Radiol. 2008;38(9):936\u201352.","journal-title":"Pediatr Radiol"},{"issue":"6","key":"269_CR33","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/sj.ejhg.5201402","volume":"13","author":"O Sancak","year":"2005","unstructured":"Sancak O, Nellist M, Goedbloed M, Elfferich P, Wouters C, Maat-Kievit A, et al. Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype: phenotype correlations and comparison of diagnostic DNA techniques in tuberous sclerosis complex. Eur J Hum Genet. 2005;13(6):731\u201341.","journal-title":"Eur J Hum Genet"},{"issue":"Suppl 1","key":"269_CR34","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1007\/s00428-007-0450-3","volume":"451","author":"M Anlauf","year":"2007","unstructured":"Anlauf M, Garbrecht N, Bauersfeld J, Schmitt A, Henopp T, Komminoth P, et al. Hereditary neuroendocrine tumors of the gastroenteropancreatic system. Virchows Arch. 2007;451 Suppl 1:S29\u201338.","journal-title":"Virchows Arch"},{"issue":"4","key":"269_CR35","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1528-1167.2007.01035.x","volume":"48","author":"GL Holmes","year":"2007","unstructured":"Holmes GL, Stafstrom CE. Tuberous sclerosis complex and epilepsy: recent developments and future challenges. Epilepsia. 2007;48(4):617\u201330.","journal-title":"Epilepsia"},{"issue":"12","key":"269_CR36","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1177\/088307389801301206","volume":"13","author":"ES Roach","year":"1998","unstructured":"Roach ES, Gomez MR, Northrup H. Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria. J Child Neurol. 1998;13(12):624\u20138.","journal-title":"J Child Neurol"},{"issue":"5","key":"269_CR37","doi-asserted-by":"crossref","first-page":"665","DOI":"10.5858\/2009-0637-RSR.1","volume":"135","author":"O Mete","year":"2011","unstructured":"Mete O, van der Kwast TH. Epithelioid angiomyolipoma: a morphologically distinct variant that mimics a variety of intra-abdominal neoplasms. Arch Pathol Lab Med. 2011;135(5):665\u201370.","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"269_CR38","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00428-007-0509-1","volume":"452","author":"G Martignoni","year":"2008","unstructured":"Martignoni G, Pea M, Reghellin D, Zamboni G, Bonetti F. PEComas: the past, the present and the future. Virchows Archive. 2008;452(2):119\u201332.","journal-title":"Virchows Archive"},{"issue":"2","key":"269_CR39","doi-asserted-by":"crossref","first-page":"R251","DOI":"10.1093\/hmg\/ddi260","volume":"14","author":"DJ Kwiatkowski","year":"2005","unstructured":"Kwiatkowski DJ, Manning BD. Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways. Hum Mol Genet. 2005;14(2):R251\u20138.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"269_CR40","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1528-1167.2007.01270.x","volume":"49","author":"M Wong","year":"2008","unstructured":"Wong M. Mechanisms of epileptogenesis in tuberous sclerosis complex and related malformations of cortical development with abnormal glioneuronal proliferation. Epilepsia. 2008;49(1):8\u201321.","journal-title":"Epilepsia"},{"issue":"1","key":"269_CR41","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1528-1167.2008.01814.x","volume":"50","author":"P Major","year":"2009","unstructured":"Major P, Rakowski S, Simon MV, Cheng ML, Eskandar E, Baron J, et al. Are cortical tubers epileptogenic? Evidence from electrocorticography. Epilepsia. 2009;50(1):147\u201354.","journal-title":"Epilepsia"},{"issue":"9","key":"269_CR42","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1177\/08830738040190090901","volume":"19","author":"HL Weiner","year":"2004","unstructured":"Weiner HL, Ferraris N, LaJoie J, Miles D, Devinsky O. Epilepsy surgery for children with tuberous sclerosis complex. J Child Neurol. 2004;19(9):687\u20139.","journal-title":"J Child Neurol"},{"issue":"3","key":"269_CR43","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.yebeh.2008.05.010","volume":"13","author":"CM Kopp","year":"2008","unstructured":"Kopp CM, Muzykewicz DA, Staley BA, Thiele EA, Pulsifer MB. Behavior problems in children with tuberous sclerosis complex and parental stress. Epilepsy Behavior. 2008;13(3):505\u201310.","journal-title":"Epilepsy Behavior"},{"issue":"8","key":"269_CR44","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1212\/01.WNL.0000142039.14522.1A","volume":"63","author":"S Goh","year":"2004","unstructured":"Goh S, Butler W, Thiele EA. Subependymal giant cell tumors in tuberous sclerosis complex. Neurology. 2004;63(8):1457\u201361.","journal-title":"Neurology"},{"issue":"6","key":"269_CR45","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1468-1331.2009.02567.x","volume":"16","author":"ME Adriaensen","year":"2009","unstructured":"Adriaensen ME, Schaefer-Prokop CM, Stijnen T, Duyndam DA, Zonnenberg BA, Prokop M. Prevalence of subependymal giant cell tumors in patients with tuberous sclerosis and a review of the literature. Eur J Neurol. 2009;16(6):691\u20136.","journal-title":"Eur J Neurol"},{"issue":"9","key":"269_CR46","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1177\/08830738040190090601","volume":"19","author":"P Prather","year":"2004","unstructured":"Prather P, de Vries PJ. Behavioral and cognitive aspects of tuberous sclerosis complex. J Child Neurol. 2004;19(9):666\u201374.","journal-title":"J Child Neurol"},{"issue":"9","key":"269_CR47","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1177\/08830738040190090801","volume":"19","author":"EA Thiele","year":"2004","unstructured":"Thiele EA. Managing epilepsy in tuberous sclerosis complex. J Child Neurol. 2004;19(9):680\u20136.","journal-title":"J Child Neurol"},{"key":"269_CR48","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2147\/NDT.S4488","volume":"5","author":"CY Tsao","year":"2009","unstructured":"Tsao CY. Current trends in the treatment of infantile spasms. Neuropsychiatric Diseases and Treatment. 2009;5:289\u201399.","journal-title":"Neuropsychiatric Diseases and Treatment"},{"issue":"10","key":"269_CR49","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/j.1365-2788.2009.01208.x","volume":"53","author":"D Ehninger","year":"2009","unstructured":"Ehninger D, de Vries PJ, Silva AJ. From mTOR to cognition: molecular and cellular mechanisms of cognitive impairments in tuberous sclerosis. J Intellect Disabil Res. 2009;53(10):838\u201351.","journal-title":"J Intellect Disabil Res"},{"issue":"10","key":"269_CR50","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1177\/0883073809341272","volume":"24","author":"E D'Agati","year":"2009","unstructured":"D'Agati E, Moavero R, Cerminara C, Curatolo P. Attention-deficit hyperactivity disorder (ADHD) and tuberous sclerosis complex. J Child Neurol. 2009;24(10):1282\u20137.","journal-title":"J Child Neurol"},{"issue":"1","key":"269_CR51","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1212\/01.wnl.0000250330.44291.54","volume":"68","author":"EB Winterkorn","year":"2007","unstructured":"Winterkorn EB, Pulsifer MB, Thiele EA. Cognitive prognosis of patients with tuberous sclerosis complex. Neurology. 2007;68(1):62\u20134.","journal-title":"Neurology"},{"issue":"5","key":"269_CR52","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1183\/09031936.06.00113303","volume":"27","author":"SR Johnson","year":"2006","unstructured":"Johnson SR. Lymphangioleiomyomatosis. Eur Respir J. 2006;27(5):1056\u201365.","journal-title":"Eur Respir J"},{"issue":"10","key":"269_CR53","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/sj.ejhg.5201625","volume":"14","author":"JR Yates","year":"2006","unstructured":"Yates JR. Tuberous sclerosis. Eur J Hum Genet. 2006;14(10):1065\u201373.","journal-title":"Eur J Hum Genet"},{"issue":"9","key":"269_CR54","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1177\/08830738040190091001","volume":"19","author":"DN Franz","year":"2004","unstructured":"Franz DN. Non-neurologic manifestations of tuberous sclerosis complex. J Child Neurol. 2004;19(9):690\u20138.","journal-title":"J Child Neurol"},{"issue":"1","key":"269_CR55","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1464-410X.2009.08649.x","volume":"105","author":"P Sooriakumaran","year":"2010","unstructured":"Sooriakumaran P, Gibbs P, Coughlin G, Attard V, Elmslie F, Kingswood C, et al. Angiomyolipomata: challenges, solutions, and future prospects based on over 100 cases treated. BJU Int. 2010;105(1):101\u20136.","journal-title":"BJU Int"},{"issue":"2","key":"269_CR56","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1378\/chest.07-0898","volume":"133","author":"FX McCormack","year":"2008","unstructured":"McCormack FX. Lymphangioleiomyomatosis: a clinical update. Chest. 2008;133(2):507\u201316.","journal-title":"Chest"},{"issue":"2","key":"269_CR57","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/med.20049","volume":"26","author":"J Jozwiak","year":"2006","unstructured":"Jozwiak J, Jozwiak S, Oldak M. Molecular activity of sirolimus and its possible application in tuberous sclerosis treatment. Med Res Rev. 2006;26(2):160\u201380.","journal-title":"Med Res Rev"},{"issue":"10","key":"269_CR58","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1055\/s-0029-1223267","volume":"26","author":"H Isaacs","year":"2009","unstructured":"Isaacs H. Perinatal (fetal and neonatal) tuberous sclerosis: a review. Am J Perinatol. 2009;26(10):755\u201360.","journal-title":"Am J Perinatol"},{"issue":"1","key":"269_CR59","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cub.2007.11.066","volume":"18","author":"CM Johannessen","year":"2008","unstructured":"Johannessen CM, Johnson BW, Williams SM, Chan AW, Reczek EE, Lynch RC, et al. TORC1 is essential for NF1-associated malignancies. Curr Biol. 2008;18(1):56\u201362.","journal-title":"Curr Biol"},{"issue":"7","key":"269_CR60","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2174\/138920208786241243","volume":"9","author":"V Napolioni","year":"2008","unstructured":"Napolioni V, Curatolo P. Genetics and molecular biology of tuberous sclerosis complex. Curr Genom. 2008;9(7):475\u201387.","journal-title":"Curr Genom"},{"issue":"3","key":"269_CR61","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.bbapap.2009.12.001","volume":"1804","author":"RJ Dowling","year":"2010","unstructured":"Dowling RJ, Topisirovic I, Fonseca BD, Sonenberg N. Dissecting the role of mTOR: lessons from mTOR inhibitors. Biochim Biophys Acta. 2010;1804(3):433\u20139.","journal-title":"Biochim Biophys Acta"},{"issue":"18","key":"269_CR62","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1101\/gad.1685008","volume":"22","author":"YJ Choi","year":"2008","unstructured":"Choi YJ, Di Nardo A, Kramvis I, Meikle L, Kwiatkowski DJ, Sahin M, et al. Tuberous sclerosis complex proteins control axon formation. Genes Dev. 2008;22(18):2485\u201395.","journal-title":"Genes Dev"},{"issue":"8","key":"269_CR63","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.molmed.2007.06.003","volume":"13","author":"PJ Vries de","year":"2007","unstructured":"de Vries PJ, Howe CJ. The tuberous sclerosis complex proteins: a GRIPP on cognition and neurodevelopment. Trends Mol Med. 2007;13(8):319\u201326.","journal-title":"Trends Mol Med"},{"issue":"2","key":"269_CR64","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.pediatrneurol.2009.08.001","volume":"42","author":"ML Krishnan","year":"2010","unstructured":"Krishnan ML, Commowick O, Jeste SS, Weisenfeld N, Hans A, Gregas MC, et al. Diffusion features of white matter in tuberous sclerosis with tractography. Pediatr Neurol. 2010;42(2):101\u20136.","journal-title":"Pediatr Neurol"},{"issue":"21","key":"269_CR65","doi-asserted-by":"crossref","first-page":"5546","DOI":"10.1523\/JNEUROSCI.5540-06.2007","volume":"27","author":"L Meikle","year":"2007","unstructured":"Meikle L, Talos DM, Onda H, Pollizzi K, Rotenberg A, Sahin M, et al. A mouse model of tuberous sclerosis: neuronal loss of Tsc1 causes dysplastic and ectopic neurons, reduced myelination, seizure activity, and limited survival. J Neurosci. 2007;27(21):5546\u201358.","journal-title":"J Neurosci"},{"issue":"2","key":"269_CR66","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.braindev.2008.09.013","volume":"31","author":"V Napolioni","year":"2009","unstructured":"Napolioni V, Moavero R, Curatolo P. Recent advances in neurobiology of tuberous sclerosis complex. Brain Dev. 2009;31(2):104\u201313.","journal-title":"Brain Dev"},{"issue":"1","key":"269_CR67","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.bbapap.2007.08.015","volume":"1784","author":"L Swiech","year":"2008","unstructured":"Swiech L, Perycz M, Malik A, Jaworski J. Role of mTOR in physiology and pathology of the nervous system. Biochim Biophys Acta. 2008;1784(1):116\u201332.","journal-title":"Biochim Biophys Acta"},{"issue":"12","key":"269_CR68","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1038\/nn1566","volume":"8","author":"SF Tavazoie","year":"2005","unstructured":"Tavazoie SF, Alvarez VA, Ridenour DA, Kwiatkowski DJ, Sabatini BL. Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2. Nat Neurosci. 2005;8(12):1727\u201334.","journal-title":"Nat Neurosci"},{"issue":"9","key":"269_CR69","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1177\/08830738040190091301","volume":"19","author":"PB Crino","year":"2004","unstructured":"Crino PB. Molecular pathogenesis of tuber formation in tuberous sclerosis complex. J Child Neurol. 2004;19(9):716\u201325.","journal-title":"J Child Neurol"},{"issue":"11","key":"269_CR70","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s00381-010-1128-8","volume":"26","author":"R Moavero","year":"2010","unstructured":"Moavero R, Cerminara C, Curatolo P. Epilepsy secondary to tuberous sclerosis: lessons learned and current challenges. Childs Nerv Syst. 2010;26(11):1495\u2013504.","journal-title":"Childs Nerv Syst"},{"issue":"8","key":"269_CR71","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1788","volume":"14","author":"D Ehninger","year":"2008","unstructured":"Ehninger D, Han S, Shilyansky C, Zhou Y, Li W, Kwiatkowski DJ, et al. Reversal of learning deficits in a Tsc2+\/\u2212 mouse model of tuberous sclerosis. Nat Med. 2008;14(8):843\u20138.","journal-title":"Nat Med"},{"issue":"Pt 1","key":"269_CR72","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1042\/BST0370259","volume":"37","author":"JR Sampson","year":"2009","unstructured":"Sampson JR. Therapeutic targeting of mTOR in tuberous sclerosis. Biochem Soc Trans. 2009;37(Pt 1):259\u201364.","journal-title":"Biochem Soc Trans"},{"issue":"1","key":"269_CR73","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1528-1167.2009.02341.x","volume":"51","author":"M Wong","year":"2010","unstructured":"Wong M. Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: from tuberous sclerosis to common acquired epilepsies. Epilepsia. 2010;51(1):27\u201336.","journal-title":"Epilepsia"},{"issue":"4","key":"269_CR74","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ana.21331","volume":"63","author":"LH Zeng","year":"2008","unstructured":"Zeng LH, Xu L, Gutmann DH, Wong M. Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex. Ann Neurol. 2008;63(4):444\u201353.","journal-title":"Ann Neurol"},{"issue":"67","key":"269_CR75","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1126\/scisignal.267pe24","volume":"2","author":"DA Guertin","year":"2009","unstructured":"Guertin DA, Sabatini DM. The pharmacology of mTOR inhibition. Sci Signal. 2009;2(67):e24.","journal-title":"Sci Signal"},{"issue":"1\u20133","key":"269_CR76","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s12026-008-8038-9","volume":"42","author":"VI Brown","year":"2008","unstructured":"Brown VI, Seif AE, Reid GS, Teachey DT, Grupp SA. Novel molecular and cellular therapeutic targets in acute lymphoblastic leukemia and lymphoproliferative disease. Immunol Res. 2008;42(1\u20133):84\u2013105.","journal-title":"Immunol Res"},{"issue":"2","key":"269_CR77","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.bbrc.2007.07.151","volume":"362","author":"A Akcakanat","year":"2007","unstructured":"Akcakanat A, Singh G, Hung MC, Meric-Bernstam F. Rapamycin regulates the phosphorylation of rictor. Biochem Biophys Res Commun. 2007;362(2):330\u20133.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"269_CR78","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.molcel.2006.03.029","volume":"22","author":"DD Sarbassov","year":"2006","unstructured":"Sarbassov DD, Ali SM, Sengupta S, Sheen JH, Hsu PP, Bagley AF, et al. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt\/PKB. Mol Cell. 2006;22(2):159\u201368.","journal-title":"Mol Cell"},{"issue":"8","key":"269_CR79","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1182\/blood-2006-06-030833","volume":"109","author":"Z Zeng","year":"2007","unstructured":"Zeng Z, Sarbassov DD, Samudio IJ, Yee KW, Munsell MF, Ellen JC, et al. Rapamycin derivatives reduce mTORC2 signaling and inhibit AKT activation in AML. Blood. 2007;109(8):3509\u201312.","journal-title":"Blood"},{"issue":"10","key":"269_CR80","doi-asserted-by":"crossref","first-page":"727","DOI":"10.7164\/antibiotics.28.727","volume":"28","author":"SN Sehgal","year":"1975","unstructured":"Sehgal SN, Baker H, Vezina C. Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization. J Antibiot (Tokyo). 1975;28(10):727\u201332.","journal-title":"J Antibiot (Tokyo)"},{"issue":"1","key":"269_CR81","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1523-1755.2001.00460.x","volume":"59","author":"RN Saunders","year":"2001","unstructured":"Saunders RN, Metcalfe MS, Nicholson ML. Rapamycin in transplantation: a review of the evidence. Kidney Int. 2001;59(1):3\u201316.","journal-title":"Kidney Int"},{"issue":"3","key":"269_CR82","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/ana.20784","volume":"59","author":"DN Franz","year":"2006","unstructured":"Franz DN, Leonard J, Tudor C, Chuck G, Care M, Sethuraman G, et al. Rapamycin causes regression of astrocytomas in tuberous sclerosis complex. Ann Neurol. 2006;59(3):490\u20138.","journal-title":"Ann Neurol"},{"issue":"19","key":"269_CR83","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMoa1001671","volume":"363","author":"DA Krueger","year":"2010","unstructured":"Krueger DA, Care MM, Holland K, Agricola A, Tudor C, Mangeshkar P, et al. Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis. N Engl J Med. 2010;363(19):1801\u201311.","journal-title":"N Engl J Med"},{"key":"269_CR84","unstructured":"Afinitor\u00ae (everolimus) tablets for oral administration [prescribing information]. East Hanover, NJ: Novartis Pharmaceuticals Corp.; 2010."},{"issue":"2","key":"269_CR85","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa063564","volume":"358","author":"JJ Bissler","year":"2008","unstructured":"Bissler JJ, McCormack FX, Young LR, Elwing JM, Chuck G, Leonard JM, et al. Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N Engl J Med. 2008;358(2):140\u201351.","journal-title":"N Engl J Med"},{"issue":"3","key":"269_CR86","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1586\/14737175.8.3.457","volume":"8","author":"P Curatolo","year":"2008","unstructured":"Curatolo P, D'Argenzio L, Cerminara C, Bombardieri R. Management of epilepsy in tuberous sclerosis complex. Expert Rev Neurother. 2008;8(3):457\u201367.","journal-title":"Expert Rev Neurother"},{"issue":"5","key":"269_CR87","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2165\/00148581-200810050-00004","volume":"10","author":"DA Krueger","year":"2008","unstructured":"Krueger DA, Franz DN. Current management of tuberous sclerosis complex. Paediatric Drugs. 2008;10(5):299\u2013313.","journal-title":"Paediatric Drugs"},{"issue":"2","key":"269_CR88","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/WCO.0b013e32832c4ff5","volume":"23","author":"KC Ess","year":"2010","unstructured":"Ess KC. Tuberous sclerosis complex: a brave new world? Curr Opin Neurol. 2010;23(2):189\u201393.","journal-title":"Curr Opin Neurol"},{"issue":"1","key":"269_CR89","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ijcard.2007.07.152","volume":"132","author":"J Jozwiak","year":"2009","unstructured":"Jozwiak J, Sahin M, Jozwiak S, Kotulska K, Ploski R, Szperl M, et al. Cardiac rhabdomyoma in tuberous sclerosis: hyperactive Erk signaling. Int J Cardiol. 2009;132(1):145\u20137.","journal-title":"Int J Cardiol"},{"issue":"2","key":"269_CR90","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2350\/06-11-0191.1","volume":"12","author":"K Kotulska","year":"2009","unstructured":"Kotulska K, Larysz-Brysz M, Grajkowska W, Jozwiak J, Wlodarski P, Sahin M, et al. Cardiac rhabdomyomas in tuberous sclerosis complex show apoptosis regulation and mTOR pathway abnormalities. Pediatr Dev Pathol. 2009;12(2):89\u201395.","journal-title":"Pediatr Dev Pathol"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-012-0269-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11910-012-0269-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-012-0269-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T11:05:09Z","timestamp":1642158309000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11910-012-0269-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,29]]},"references-count":90,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["269"],"URL":"https:\/\/doi.org\/10.1007\/s11910-012-0269-4","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,29]]}}}